• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对肝豆状核变性患者不同疾病阶段不同致病因素的研究。

Study on different pathogenic factors in different disease stages of patients with Wilson disease.

机构信息

Department of Neurology, The East Area of the First Affiliated Hospital, Sun Yat-Sen University, HuangPu East Street, 183#, Guangzhou, Guangdong, China.

Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, No. 58 Zhongshan Road 2, Guangzhou, 510080, China.

出版信息

Neurol Sci. 2021 Sep;42(9):3749-3756. doi: 10.1007/s10072-020-04973-7. Epub 2021 Jan 14.

DOI:10.1007/s10072-020-04973-7
PMID:33443665
Abstract

OBJECTIVE

To investigate in different stages of patients with Wilson disease (WD), there are different pathogenic factors such as metal deposition, oxidative stress, and inflammatory response in the brain.

METHODS

A total of 32 untreated WD patients and 10 normal controls were enrolled in the study. The neurological symptoms were evaluated using the modified Young scale. Liver function, metal metabolism, susceptibility-weighted imaging (SWI), diffusion tensor imaging (DTI), and magnetic resonance spectroscopy (MRS) examination were done. The clinical disease stages were divided into metal deposition period, fiber damage period, and neuronal necrosis period according to the imaging results. The content of 24-h urine copper, serum copper, and serum iron; and the levels of catalase (CAT), glutathione peroxidase (GSH-PX), malondialdehyde (MDA), nitric oxide (NO), nitric oxide synthase (NOS), superoxide dismutase (SOD), interleukin (IL-1), and tumor necrosis factor alpha (TNF-α) were detected.

RESULTS

The contents of urinary copper in WD patients at neuronal necrosis stage were lower than those in patients at the metal deposition stage (P = 0.011) and fiber injury stage (P = 0.023). The contents of NOS (P = 0.039) and NO (P = 0.047) in WD patients at the stage of fiber injury were higher than those of the normal control, while GSH-PX (P = 0.025) and CAT (P = 0.041) were lower in the neuronal necrosis stage. In the stage of neuronal necrosis, the levels of IL-1 (P = 0.030) and TNF-α were higher than those of the normal control (P = 0.042). The neurological symptom scores in patients with fiber injury (P = 0.013) and neuron injury were higher than those with metal deposition (P = 0.026).

CONCLUSION

There are different pathogenic factors in different stages of WD. At the neuronal necrosis stage, copper deposition was decreased in WD patients. In the stage of fiber injury and neuronal necrosis, there is oxidative stress injury in WD patients. In the neuronal necrosis phase, WD patients have an inflammatory response.

摘要

目的

探讨肝豆状核变性(WD)不同阶段患者脑内存在不同的致病因素,如金属沉积、氧化应激和炎症反应。

方法

共纳入 32 例未经治疗的 WD 患者和 10 例正常对照者。采用改良 Young 量表评估神经症状。进行肝功能、金属代谢、磁敏感加权成像(SWI)、弥散张量成像(DTI)和磁共振波谱(MRS)检查。根据影像学结果将临床疾病阶段分为金属沉积期、纤维损伤期和神经元坏死期。检测 24 小时尿铜、血清铜和血清铁含量,以及过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-PX)、丙二醛(MDA)、一氧化氮(NO)、一氧化氮合酶(NOS)、超氧化物歧化酶(SOD)、白细胞介素(IL-1)和肿瘤坏死因子α(TNF-α)水平。

结果

神经元坏死期 WD 患者尿铜含量低于金属沉积期(P=0.011)和纤维损伤期(P=0.023)。纤维损伤期 WD 患者 NOS(P=0.039)和 NO(P=0.047)含量高于正常对照组,而神经元坏死期 GSH-PX(P=0.025)和 CAT(P=0.041)含量较低。在神经元坏死期,IL-1(P=0.030)和 TNF-α 水平高于正常对照组(P=0.042)。纤维损伤(P=0.013)和神经元损伤患者的神经症状评分高于金属沉积患者(P=0.026)。

结论

WD 不同阶段存在不同的致病因素。在神经元坏死期,WD 患者铜沉积减少。在纤维损伤期和神经元坏死期,WD 患者存在氧化应激损伤。在神经元坏死期,WD 患者存在炎症反应。

相似文献

1
Study on different pathogenic factors in different disease stages of patients with Wilson disease.对肝豆状核变性患者不同疾病阶段不同致病因素的研究。
Neurol Sci. 2021 Sep;42(9):3749-3756. doi: 10.1007/s10072-020-04973-7. Epub 2021 Jan 14.
2
Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease.Wilson 病患者停用金属螯合剂治疗后症状加重。
Brain Behav. 2023 Sep;13(9):e3170. doi: 10.1002/brb3.3170. Epub 2023 Jul 26.
3
[Difference in imaging and metal metabolism between hepatic and cerebral type Wilson disease].肝型和脑型威尔逊病在影像学及金属代谢方面的差异
Zhonghua Yi Xue Za Zhi. 2017 Jan 17;97(3):176-181. doi: 10.3760/cma.j.issn.0376-2491.2017.03.004.
4
A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator.金属螯合剂治疗Wilson 病患者时的磁敏感加权成像研究。
J Neurol. 2020 Jun;267(6):1643-1650. doi: 10.1007/s00415-020-09746-y. Epub 2020 Feb 14.
5
[Clinical characteristics of patients with delayed hepatolenticular degeneration].[迟发性肝豆状核变性患者的临床特征]
Zhonghua Nei Ke Za Zhi. 2019 Jul 1;58(7):501-507. doi: 10.3760/cma.j.issn.0578-1426.2019.07.004.
6
Injury factors and pathological features of toxic milk mice during different disease stages.中毒奶鼠在不同疾病阶段的损伤因素及病理特征。
Brain Behav. 2019 Dec;9(12):e01459. doi: 10.1002/brb3.1459. Epub 2019 Nov 19.
7
[Clinical characteristics of the Wilson disease carrier].[肝豆状核变性携带者的临床特征]
Zhonghua Yi Xue Za Zhi. 2019 Mar 19;99(11):806-811. doi: 10.3760/cma.j.issn.0376-2491.2019.11.002.
8
Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.利用磁敏感加权成像对威尔逊病患者脑内矿物质沉积进行特征分析。
Neurol India. 2014 Jul-Aug;62(4):362-6. doi: 10.4103/0028-3886.141221.
9
Diffusion tensor imaging of the extracorticospinal network in the brains of patients with Wilson disease.肝豆状核变性患者大脑皮质脊髓外网络的扩散张量成像
J Neurol Sci. 2016 Mar 15;362:292-8. doi: 10.1016/j.jns.2016.02.006. Epub 2016 Feb 4.
10
A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings.一项关于威尔逊病及其无症状同胞的氧化应激、细胞因子和谷氨酸的研究。
J Neuroimmunol. 2014 Sep 15;274(1-2):141-8. doi: 10.1016/j.jneuroim.2014.06.013. Epub 2014 Jun 24.

引用本文的文献

1
Extracellular Acidosis, Cysteine, and Glutathione Enhance the Toxic Effect of Copper Ions in Cultures of Cerebellar Granule Neurons.细胞外酸中毒、半胱氨酸和谷胱甘肽增强小脑颗粒神经元培养物中铜离子的毒性作用。
Bull Exp Biol Med. 2024 Sep;177(5):588-591. doi: 10.1007/s10517-024-06229-2. Epub 2024 Sep 28.
2
Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease.Wilson 病患者停用金属螯合剂治疗后症状加重。
Brain Behav. 2023 Sep;13(9):e3170. doi: 10.1002/brb3.3170. Epub 2023 Jul 26.
3
Cerebral Iron Deposition in Neurodegeneration.
脑铁沉积与神经变性疾病。
Biomolecules. 2022 May 17;12(5):714. doi: 10.3390/biom12050714.